Zsírmáj (MASLD/MASH): vizsgálatok itt: Mexikó
11 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
- Where
- Acapulco de Juárez, Cuauhtémoc, Mexico City
- Életkor
- 18 év to 80 év
- People
- 1650 worldwide
- Run by
- Akero Therapeutics, Inc
See details and how to joinNCT06215716 - No phaseCsak meghívásosEffect of Ancestry Supplementation in Subjects With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
- Where
- Guadalajara
- Életkor
- 18 év to 60 év
- People
- 60
- Run by
- University of Guadalajara
See details and how to joinNCT07592013 - 3. fázisTaking peopleLIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
- Where
- Acapulco de Juárez, Col. Xoco, Cuernavaca, Mérida, Mexico City, Veracruz, Xalapa
- Életkor
- 18 év and over
- People
- 1800 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT06632444 · EU 2024-513739-25-00 - 3. fázisTaking peopleLIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
- Where
- Acapulco de Juárez, Col. Xoco, Cuernavaca, Mérida, Mexico City, Veracruz, Xalapa
- Életkor
- 18 év and over
- People
- 1590 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT06632457 · EU 2024-513741-36-00 - 3. fázisTaking peopleA Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
- Where
- Chihuahua City, Cuautitlán Izcalli, Jalisco, Mexico City, Morelos, Nuevo León, Yucatán
- Életkor
- 18 év to 80 év
- People
- 1350 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT06318169 · EU 2023-509912-27-00 - 3. fázisTaking peopleA Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
- Where
- Chihuahua City, Cuautitlán Izcalli, Cuernavaca, Jalisco, Mérida, Mexico City, Monterrey
- Életkor
- 18 év to 75 év
- People
- 1800 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT06419374 · EU 2023-510395-31-00 - 3. fázisTaking peopleA Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
- Where
- Acapulco de Juárez, Benito Juárez, Cuauhtémoc, Guadalajara, Mérida, Mexico City
- Életkor
- 18 év to 80 év
- People
- 2150 worldwide
- Run by
- Akero Therapeutics, Inc
See details and how to joinNCT06528314 - 3. fázisTaking peopleA Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
- Where
- Chihuahua City, Cuauhtémoc, Cuernavaca, Guadalajara, Mérida, Metepec, Mexico City, Monterrey, Morelia, San Pedro Garza García, Veracruz, Zapopan
- Életkor
- 18 év and over
- People
- 4500 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07165028 · EU 2025-522674-36-00 - 4. fázisTaking peopleFibrosis Lessens After Metabolic Surgery
- Where
- Mexico City
- Életkor
- 18 év to 75 év
- People
- 120 worldwide
- Run by
- The Cleveland Clinic
See details and how to joinNCT06374875 - No phaseNot yet taking people in MexikóEffect of a Low AGE Diet on Liver Function in Adults With Fatty Liver.
- Where
- Celaya
- Életkor
- 18 év to 55 év
- People
- 48
- Run by
- Universidad de Guanajuato
See details and how to joinNCT07723196 - No phaseNot yet taking people in MexikóCARTIZ Registry: Cartilage, Arthropathy and Imaging Under Tirzepatide in Zone-stratified Cohorts - A Four-Institute Mexican Observational Registry
- Where
- Mexico City
- Életkor
- 18 év and over
- People
- 30
- Run by
- JULIO GRANADOS MONTIEL
See details and how to joinNCT07567378